Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AI Pathology, Digital Pathology Platform

Thomas Fuchs

PhD

🏢Icahn School of Medicine at Mount Sinai🌐USA

Dean of Artificial Intelligence and Human Health

57
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Thomas Fuchs is dean of AI and human health at Mount Sinai and co-founder of Paige.AI, the company that received the first FDA de novo clearance for an AI-based digital pathology system for prostate cancer detection. He has led the development and clinical validation of deep learning systems that assist pathologists in cancer diagnosis at scale. His translational work bridges laboratory AI innovation with regulatory-pathway clinical deployment.

Share:

🧪Research Fields 研究领域

digital pathology AI deployment
Paige AI pathology platform
FDA-cleared pathology AI
prostate cancer AI detection
clinical implementation AI pathology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Thomas Fuchs 的研究动态

Follow Thomas Fuchs's research updates

留下邮箱,当我们发布与 Thomas Fuchs(Icahn School of Medicine at Mount Sinai)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment